产品展示
A0425 FADD (Phospho-Ser194) Antibody
点击次数:102发布时间:2012/9/6 22:02:28
更新日期:2024/10/16 15:59:55
所 在 地:美洲
产品型号:
优质供应
详细内容
A0425 FADD (Phospho-Ser194) Antibody
Reactivity | Applications | MW. | Source |
H | WB IHC ELISA | 23 kDa | Rabbit |
Product Name | FADD (Phospho-Ser194) Antibody |
Synonyms | FAS-associating death domain-containing protein; Mediator of receptor induced toxicity; MORT1 |
Immunogen | The antiserum was produced against synthesized peptide derived from human FADD around the phosphorylation site of Ser194. |
Immunogen Region | C-terminal |
Clonality | Polyclonal |
Modification sites | H:S194 |
Application dilutions | WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:1000 |
Specificity | FADD (Phospho-Ser194) Antibody detects endogenous levels of FADD only when phosphorylated at serine194. |
Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation. |
Physical Form | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Concentration | 1 mg/ml |
Storage/Stability | Store at -20℃/1 year |
NCBI Gene Symbol | FADD | ||||||||
Database Links |
| ||||||||
Application images | Immunohistochemistry analysis of paraffin-embedded human breast carcinoma, using FADD (Phospho-Ser194) Antibody. The picture on the right is treated with the synthesized peptide. Western blot analysis of extracts from HeLa cells treated with Paclitaxel 1uM 60', using FADD (Phospho-Ser194) Antibody. The lane on the right is treated with the synthesized peptide. |
Related products |